Cover Image

Sclerostin is an independent risk factor for all-cause mortality in kidney transplant recipients

Sclerostin is a hormone contributing to the bone-vascular wall cross talk and has been implicated in cardiovascular events and mortality in patients with chronic kidney disease (CKD). We analyzed the relationship between sclerostin and mortality in renal transplant recipients.

Saved in:
Bibliographic Details
Main Authors: Zeng, Shufei (Author) , Slowinski, Torsten (Author) , Pommer, Wolfgang (Author) , Hasan, Ahmed A. (Author) , Gaballa, Mohamed Mahmoud Salem Ahmed (Author) , Lu, YongPing (Author) , Krämer, Bernhard (Author) , Hocher, Berthold (Author)
Format: Article (Journal)
Language:English
Published: 20 August 2020
In: Clinical and experimental nephrology
Year: 2020, Volume: 24, Issue: 12, Pages: 1177-1183
ISSN:1437-7799
DOI:10.1007/s10157-020-01956-y
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10157-020-01956-y
Get full text
Author Notes:Shufei Zeng, Torsten Slowinski, Wolfgang Pommer, Ahmed A. Hasan, Mohamed M. S. Gaballa, Yongping Lu, Bernhard K. Krämer, Berthold Hocher
Description
Summary:Sclerostin is a hormone contributing to the bone-vascular wall cross talk and has been implicated in cardiovascular events and mortality in patients with chronic kidney disease (CKD). We analyzed the relationship between sclerostin and mortality in renal transplant recipients.
Item Description:Gesehen am 12.08.2021
Physical Description:Online Resource
ISSN:1437-7799
DOI:10.1007/s10157-020-01956-y

Similar Items